DENTSPLY SIRONA Inc (NASDAQ:XRAY) declared a quarterly dividend on Wednesday, April 25th, RTT News reports. Stockholders of record on Friday, June 29th will be given a dividend of 0.0875 per share by the medical instruments supplier on Friday, July 13th. This represents a $0.35 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Thursday, June 28th.

Shares of DENTSPLY SIRONA opened at $44.28 on Wednesday, according to Marketbeat.com. DENTSPLY SIRONA has a one year low of $41.64 and a one year high of $68.98. The stock has a market capitalization of $10.18 billion, a price-to-earnings ratio of 17.08, a PEG ratio of 2.32 and a beta of 1.23. The company has a quick ratio of 1.46, a current ratio of 2.23 and a debt-to-equity ratio of 0.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Sunday, May 6th. The medical instruments supplier reported $0.45 EPS for the quarter, topping the consensus estimate of $0.42 by $0.03. DENTSPLY SIRONA had a negative net margin of 38.32% and a positive return on equity of 8.63%. The company had revenue of $956.10 million during the quarter, compared to analysts’ expectations of $942.20 million. During the same period last year, the company posted $0.49 earnings per share. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. analysts anticipate that DENTSPLY SIRONA will post 2.57 earnings per share for the current fiscal year.

In other news, Director Michael J. Coleman sold 6,038 shares of the stock in a transaction that occurred on Friday, June 1st. The shares were sold at an average price of $43.97, for a total value of $265,490.86. Following the completion of the sale, the director now directly owns 26,960 shares of the company’s stock, valued at $1,185,431.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Nicholas W. Alexos purchased 50,000 shares of DENTSPLY SIRONA stock in a transaction dated Wednesday, May 9th. The stock was bought at an average cost of $44.71 per share, with a total value of $2,235,500.00. Following the completion of the transaction, the chief financial officer now directly owns 25,411 shares of the company’s stock, valued at $1,136,125.81. The disclosure for this purchase can be found here. Insiders sold 7,856 shares of company stock valued at $349,153 over the last three months. 1.93% of the stock is owned by insiders.

Several research analysts have commented on XRAY shares. ValuEngine cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 8th. HC Wainwright set a $63.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a report on Tuesday, March 27th. Credit Suisse Group decreased their target price on shares of DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating for the company in a report on Friday, March 2nd. Morgan Stanley decreased their target price on shares of DENTSPLY SIRONA from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Thursday, June 14th. Finally, Barclays reiterated a “hold” rating and issued a $55.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, May 8th. Two analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $62.23.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Dividend History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.